<DOC>
	<DOCNO>NCT01808287</DOCNO>
	<brief_summary>The purpose study assess safety device success Edwards SAPIEN 3 Transcatheter Heart Valve ( S3 THV ) Edwards Commander Certitude Delivery Systems patient symptomatic , severe aortic stenosis indicate aortic valve replacement .</brief_summary>
	<brief_title>Safety Performance Study Edwards SAPIEN 3 Transcatheter Heart Valve/ The SAPIEN 3 Study</brief_title>
	<detailed_description>This non-randomized , prospective , multicenter safety device success study . Two hundred fifty ( 250 ) patient plan enrol 20 participate investigational center Europe Canada . Patient participation last minimum 5 year . Patients assess follow interval : baseline , hospital discharge , 30 day , 1 year annually thereafter minimum 5 year .</detailed_description>
	<criteria>1 . Severe symptomatic calcific aortic valve stenosis : 1 . High surgical risk : STS Score ≥ 8 EuroSCORE ≥ 15 ( first 50 patient ) , 2 . High Intermediate surgical risk : STS Score ≥ 4 EuroSCORE ≥ 10 ( patient 51 150 ) . 3 . Intermediate surgical risk : STS Score 4 8 Logistic EuroSCORE 10 15 ( subsequent patient ) ; except 20mm valve implant ( STS Score &gt; 4 EuroSCORE ≥ 10 ) . 2 . Age ≥ 75 year 3 . NYHA ≥ II 4 . Heart team ( include examine cardiac surgeon ) agree eligibility include assessment TAVR appropriate . 5 . Study patient provide write informed consent comply study procedure followup visit . 1 . Noncalcified aortic valve 2 . Acute myocardial infarction ≤ 30 day intend treatment 3 . Untreated clinically significant coronary artery disease require revascularization . 4 . Aortic valve congenital unicuspid congenital bicuspid valve . 5 . Mixed aortic valve disease ( predominant aortic regurgitation ) 6 . Preexisting bioprosthetic valve ring position 7 . For Intermediate Risk patient enrol inclusion criterion 1.c ) patient untreated preexist conduction disturbance ( AV Block Bundle Branch Block ) .</criteria>
	<gender>All</gender>
	<minimum_age>75 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Transcatheter Aortic Valve Replacement</keyword>
	<keyword>Aortic Stenosis</keyword>
</DOC>